Founded in 1933, Omron Group is an automation control and electronic equipment manufacturer. By continuously creating new social needs, Omron Group has more than 36,000 employees worldwide and a turnover of 773 billion yen. The products cover a wide range of fields such as industrial automation control systems, electronic components, automotive electronics, social systems, health and medical equipment, and have hundreds of thousands of varieties.

Since entering China in the early 1970s, Omron has been moving forward with China's manufacturing industry, building a multi-faceted management system integrating R&D, design, production, sales and service, in order to build "safety" and "safety". "Environmental and "healthy" local society has made contributions. As early as the early 1970s, Mr. Takashi Ichimaru, then vice president of the ITC Promotion General Administration, began exchanges and cooperation with China as a representative of the economic circle. After technical exchanges in the 1970s, commissioned processing in the 1980s, direct investment and production in the 1990s. Entering the 21st century, Omron ushered in a new stage of "reinvestment and collaborative creation". As of March 2014, Greater China The district's sales reached 141.1 billion yen and its employees have exceeded 15,000.

In order to realize the vision of the circulatory system business, Omron will launch the research and development of upper-arm blood sphygmomanometers and electrocardiogram analysis services equipped with electrocardiograms around the world, expanding its business to the field of "early detection and prevention of recurrence of atrial fibrillation". In addition, Omron will also create new equipment and services to support the early detection and improvement of living habit diseases that can induce hypertension and atrial fibrillation; through the development of algorithms using AI, we will be committed to early perception of disease signs and build preventive medical treatment mechanism. In China, where the number of patients with hypertension and chronic diseases is increasing, Omron will increase cooperation with doctors and medical institutions and strengthen MMC health convenience stores, a service that connects medical and family health management; in India, Omron will increase The number of Omron's product experience facilities will promote the popularization of home blood pressure measurement, and cooperate with local hospitals and partner companies to create new businesses such as blood pressure and electrocardiogram monitoring services.

In order to help more people improve respiratory diseases, in addition to asthma, the respiratory system industry has also launched a business targeting COPD (Chronic Obstructive Pneumonia). In emerging countries and other places, the number of patients with respiratory diseases is growing. In addition, since the diagnostic standards have not yet reached standardization, there are also problems with diagnosis difficulties. Omron will popularize the diagnosis and treatment of respiratory diseases in countries with an incomplete medical system; and in developed countries where medical expenses continue to rise, Omron will promote the popularization of treatment and symptom management support services, committed to reducing doctors, patients and their families. the burden of treatment.

Pain management career will challenge “with the help of new TENS (Percutaneous Electric Stimulation Neurotherapy) technology, developing new equipment” and “sports therapy support services”, Omron makes as many people as possible without fear of pain and can do the same way they like. Carry out daily life.